Approval · Notice of Compliance 13218 · 2012
VITAROS: Notice of Compliance 13218
Issued April 23, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13218
- Date
- April 23, 2012
- Company
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Treatment for Male Erectile Dysfunction
Products in this notice
Medicinal ingredients
- ALPROSTADIL 220 MCG per 100MG
- ALPROSTADIL 330 MCG per 100MG